Skip to main content

Inovio, AstraZeneca terminate cancer vaccine partnership

Plymouth Meeting-based Inovio had the potential to earn up to $700 million through the original collaboration entered into six years ago.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.